相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Perception of risk and communication among conventional and complementary health care providers involving cancer patients' use of complementary therapies: a literature review
Trine Stub et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Outcome of pleurodesis using different agents in management of malignant pleural effusion
Reham Mohammed El-Kolaly et al.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS (2016)
A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients
Alessandra Longhi et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial
Wilfried Troeger et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Mistletoe preparation (Viscum Fraxini-2) as palliative treatment for malignant pleural effusion: a feasibility study with comparison to bleomycin
Rabab Gaafar et al.
ECANCERMEDICALSCIENCE (2014)
Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival
W. Troeger et al.
EUROPEAN JOURNAL OF CANCER (2013)
P02.116. The relationship between deqi and the effect of acupuncture
Y Choi et al.
BMC Complementary and Alternative Medicine (2012)
Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis
Arndt Buessing et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
How Many Cancer Patients Use Complementary and Alternative Medicine: A Systematic Review and Metaanalysis
Markus Horneber et al.
INTEGRATIVE CANCER THERAPIES (2012)
Five-Year Follow-Up of patients with early stage Breast cancer After a Randomized study comparing Additional Treatment with Viscum Album (L.) extract to chemotherapy Alone
Wilfried Troger et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2012)
Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies
Gunver S. Kienle et al.
INTEGRATIVE CANCER THERAPIES (2010)
Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research
Gunver S. Kienle et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
A randomized study with adjuvant mistletoe versus oral Etoposide on post relapse disease-free survival in osteosarcoma patients
Alessandra Longhi et al.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE (2009)
Efficacy and Safety of the Long-term Treatment of Melanoma with a Mistletoe Preparation (Iscador)
Ronald Grossarth-Maticek et al.
SCHWEIZERISCHE ZEITSCHRIFT FUER GANZHEITSMEDIZIN (2007)
Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients
M Steuer-Vogt et al.
HNO (2006)
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial:: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis
UR Kleeberg et al.
EUROPEAN JOURNAL OF CANCER (2004)
Mistletoe for cancer? A systematic review of randomised clinical trials
E Ernst et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
The influence of Isorel on the advanced colorectal cancer
M Cazacu et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2003)
Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer:: A randomized phase II trial
PJ Goebell et al.
JOURNAL OF UROLOGY (2002)